logo
Wisconsin has seen progress in reducing overdose deaths. Trump's cuts could upend that.

Wisconsin has seen progress in reducing overdose deaths. Trump's cuts could upend that.

Yahoo15-05-2025
A new report from the U.S. Centers for Disease Control reinforces earlier data showing an ongoing decline in overdose deaths nationwide, and repeats the contention that one of the main reasons for the progress is an approach called harm reduction.
Despite these advances, the Trump administration has proposed eliminating federal grants for harm reduction efforts, a move that Wisconsin public health officials warn could stall gains made in drug overdose prevention. Those concerns were amplified by more than 320 behavioral medicine academic experts, who wrote to congressional leaders May 12 decrying the cuts to these life-saving overdose prevention services.
In February 2025, the CDC released a promising report with provisional data showing that from October 2023 to September 2024, overdose deaths had dropped by more than 27,000. Dr. Allison Arwady, director of the National Center for Injury Prevention and Control, called the nearly 24% decline unprecedented.
The widespread distribution of naloxone, a key product of the federal harm reduction program, was a crucial factor in this milestone, the report found. Naloxone, known by the brand name Narcan, reverses life-threatening symptoms associated with opioid overdoses.
Related: Wisconsin records significant drop in overdose deaths, although officials remain cautious
Now, on May 14, the CDC has released a second provisional report showing an even more profound decline from that 12-month time period ― a nearly 27% drop in overdose deaths. The decline in overdose deaths has steadily continued from month to month, the report said. It strongly supported the idea that these strides can be attributed to public health interventions.
Harm reduction makes up one of the four pillars of an overdose prevention strategy prioritized by the U.S. Department of Health and Human Services after Trump declared a national emergency on the opioid epidemic in his first presidential term. The approach promotes getting critical health services to people regardless of whether they use drugs, including safe syringe programs, fentanyl and xylazine testing strips, and the distribution of naloxone or Narcan.
"We accept that, for better or worse, people use drugs. We work to minimize risks and harm that come with drug use," said Dr. Julia Olsen, a supervisor at Public Health Madison & Dane County. "We don't condemn or judge people for their use. We try to meet them where they're at and make sure they can be as healthy, safe and well as they can be."
In his second term, the Trump administration is walking back aspects of the overdose strategy his first administration spearheaded. In his discretionary budget to Congress shared on the White House website May, Trump has proposed removing harm reduction services from the equation, saying the Biden-Harris administration used the approach "to fund dangerous activities … which included funding 'safe smoking kits and supplies' and 'syringes' for drug users."
Findings from the Substance Abuse and Mental Health Services Administration tell a different story. The health agency has written several reports suggesting that harm reduction efforts are a powerful public health approach, not only when it comes to mitigating overdoses, but removing stigmas and making safer choices, even when using illicit drugs.
"Of course, we want to prevent these overdoses from happening, but at the same time, we have to recognize that we have a problem on our hands right now, in Milwaukee County, in Wisconsin, in the United States," said Dr. Ben Weston, chief health policy advisor for Milwaukee County. "We need to address that to save lives, and that's where harm reduction comes in."
Milwaukee County has used harm reduction as part of its overdose prevention strategy for years. The county won $101 million from opioid settlement funds in two settlement agreements, one in 2021 and the other in 2023, with companies that supplied opioids. The County Board allocated $11 million to install 11 new vending machines at specific locations — a health center, a concert venue, a social service agency and more — and packing them with free supplies like Narcan, fentanyl testing strips, and medication lock bags.
Related: Milwaukee County received a record $101 million opioid settlement. How will it spend the money?
Related: County exec David Crowley steers part of massive opioid settlement to treatment, prevention
Harm reduction efforts also break down barriers, Weston said. They can then be a stepping stone for medication-assisted treatment like buprenorphine and methadone, Weston said, drugs that block the opioid receptors in the brain while reducing cravings and withdrawal symptoms.
"Giving buprenorphine not just in a specialized clinic, where you have to wait several weeks to get in, but right there at the time of the 911 call, or whether they're on the street or under a bridge, in their living room, wherever, harm reduction is key to getting them those treatments," Weston said.
While the harm reduction movement has been around for decades, notably during the HIV-AIDS epidemic, it wasn't until the Biden-Harris administration that it transformed from a fringe grassroots philosophy to a federal drug policy. 2022 marked the first year that the Substance Abuse and Mental Health Services Administration, or SAMHSA, awarded 25 harm reduction grants to agencies across the country.
In October 2023, Wisconsin Department of Health Services received nearly $28 million in substance use block grants, which included harm reduction efforts. In turn, vending machines stocked with free naloxone nasal spray, fentanyl strips and medication lock bags started cropping up on busy streets, in schools, health care clinics and libraries, and in sheriff's departments.
In 2024, Milwaukee County saw its most dramatic drop in drug overdose deaths since 2018, a decline of nearly 28% from a year earlier.
"Harm reduction is saving lives, which is critical," Weston said.
Related: As DOGE slashes funding source, Wisconsin behavioral treatment centers worry about programs
Related: Milwaukee County unveils new overdose dashboard, ushering new hopes of driving down deaths
Olsen, in Dane County, said that while it's difficult to prove causation, the county's received fewer non-fatal overdose calls to emergency medical services (EMS) since the state starting ramping up its harm reduction efforts. And over the last few years, more than 14,000 people have used the harm reduction services at its three public health offices in Madison.
Olsen and Weston both told the Milwaukee Journal Sentinel that access to harm reduction services led to those same people making healthier choices in other areas of their lives. Syringe services, for example, reduce the risks of contracting and transmitting HIV and viral hepatitis, but while there, people can learn about safer injection practices, vaccinations, wound care, and how to get access to social and mental health services.
The Trump administration plans to consolidate several programs, including SAMHSA, into a unified entity under the new Administration for a Healthy America, which will focus on chronic disease prevention, maternal and child health, and mental health services. The budget would retain $5.7 billion "for activities that were formerly part of SAMHSA," according to the discretionary budget.
It would not include the $56 million annual grant through SAMHSA that distributes overdose-reversing kits and trains first responders in how to administer naloxone.
Proponents of Trump's budget, which would cut a quarter of Health and Human Services, including more than a $1 billion from SAMHSA, have argued the cuts are necessary to "streamline operations, enhance responsiveness to the American people, and ultimately improve the nation's health as part of the Make America Healthy Again initiative," HHS press secretary Vianca Rodriguez Feliciano told the Milwaukee Journal Sentinel in an email. Feliciano offered no specifics on how the cuts would improve the nation's health.
Widespread cuts like this, public health officials argue, will reduce access to supplies and resources at a time when communities in Wisconsin and beyond are starting to see the benefits of the federal overdose prevention strategy.
Rhetoric from the White House, too, risks growing misconceptions of what harm reduction is and, significantly, what it is not. Already, the biggest falsehood Weston and Olsen encounter is that harm reduction enables drug use.
"Teenagers don't decide to start doing heroin because they know they could get naloxone," Olsen said. "That's just not how addiction progresses for people."
Instead, harm reduction offers an opportunity to save lives, Weston said.
"Anybody who knows somebody who has died from an overdose will tell you that they wish that person could have another chance, and they wish they could have intervened, that maybe they could have made a difference," Weston said. "Harm reduction is that difference."
Natalie Eilbert covers mental health issues for the Milwaukee Journal Sentinel. She welcomes story tips and feedback. You can reach her at neilbert@gannett.com or view her X (Twitter) profile at @natalie_eilbert.
This article originally appeared on Milwaukee Journal Sentinel: Harm prevention efforts have cut drug OD deaths. Why is Trump opposed?
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Rebalancing Pharmaceutical Pricing Without Sacrificing Innovation
Rebalancing Pharmaceutical Pricing Without Sacrificing Innovation

Forbes

time31 minutes ago

  • Forbes

Rebalancing Pharmaceutical Pricing Without Sacrificing Innovation

Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. (Photo by) Getty Images Two weeks ago, President Trump sent letters to 17 leading pharmaceutical manufacturers, giving them 60 days to propose plans to lower U.S. drug prices to align with the lowest prices offered in other developed nations. This is an opportunity to recalibrate pharmaceutical pricing in a way that brings relief to U.S. consumers, corrects global imbalances and safeguards innovation, a transition the entire healthcare ecosystem must eventually adopt. Most discussions about drug prices focus narrowly on the retail cost patients see at the pharmacy counter, but these are only a fraction of the real economic picture. Trump's directive aims to address a decades-long imbalance: Americans pay significantly more for the same products than consumers abroad, in effect subsidizing both foreign healthcare systems and pharmaceutical profits. The 'most favored nation' concept could give consumers better pricing, but it also raises critical questions about sustaining innovation and ensuring access. By putting pharmaceutical manufacturers on the clock, the administration signals a willingness to use negotiation and policy leverage, similar to its tariff strategy, to change entrenched practices. As I've long argued in previous columns, focusing solely on high drug prices misses the larger problem: healthcare as a whole delivers too little value for what we spend. The need for transparency in both cost and quality, as well as a greater appreciation of outcomes that matter to patients, applies to every sector, from pharmaceuticals to hospital care. Pharma is a practical starting point because public attention is already here, but the real target is an ecosystem-wide business model change. Without a broad value-based framework and a clear vision of how to proceed, reforms will default to piecemeal fixes that merely shift costs from one part of the system to another. Some policymakers have advocated for blunt price caps as a quick solution to escalating drug prices. Experience shows this approach distorts markets, erodes innovation and ultimately harms patients, the topic of one of my past columns. In Europe, where prices are heavily controlled, access to new therapies can be delayed or denied, a cautionary example for the U.S. Innovation is inherently risky: only a fraction of drug candidates ever reach the market, and the returns on successful products fund the failures. Suppressing returns discourages the investment needed for breakthrough discoveries. The goal should be rebalancing—with Europe paying more, the U.S. paying less—not penalizing one of America's most important and competitive industries. The administration has made it clear it is prepared to disrupt the status quo. Disruption is most productive when it's channeled toward structural reform. Pharmaceutical pricing reform can set a precedent for other segments of healthcare—delivery systems, payers and PBMs—where misaligned incentives drive up costs without improving outcomes. Stakeholders should view the 60-day deadline not just as a compliance exercise but as an invitation to propose creative, sustainable models that link payment to measurable results. This is a rare alignment of political will, public attention and market readiness, an environment conducive to bold experimentation. If the industry responds defensively or minimally, the likely result will be more prescriptive regulation and less flexibility to innovate. Conversely, failure to address pricing inequities will keep U.S. consumers shouldering disproportionate costs, fueling political pressure for heavy-handed solutions. Past decades of incremental tweaks have left us with a fragmented, opaque system. The risk now is that we repeat that pattern rather than rethinking the fundamentals. Rebalancing pharmaceutical pricing is not about punishing one sector or enacting price controls. It's about creating a market where cost reflects value, competition rewards innovation and consumers benefit from both affordability and access. Pharmaceutical companies are simply the first to face this scrutiny, but the value conversation must extend to every corner of healthcare delivery. This moment, if met with creativity and commitment, can be a catalyst for systemic change that has eluded us for decades.

CDC shooter Patrick Joseph White's dad repeatedly called 911 fearing he was gunman
CDC shooter Patrick Joseph White's dad repeatedly called 911 fearing he was gunman

New York Post

timean hour ago

  • New York Post

CDC shooter Patrick Joseph White's dad repeatedly called 911 fearing he was gunman

The father of the anti-vaxxer gunman who killed a cop when he fired more than 180 shots at the US Centers for Disease Control and Prevention repeatedly called 911 fearing that his son was responsible for the attack, newly released 911 calls show. Kenneth White had begged authorities for help as his son, Patrick Joseph White, was unleashing his reign of terror on the CDC's Atlanta headquarters last Friday, according to transcripts obtained by 11Alive. 'I'm very worried that he might have been involved in this shooting today,' the dad said in one call. Advertisement 3 Documents found in a search of the home where CDC shooter Patrick Joseph Smith lived with his parents revealed his discontent with the COVID-19 vaccinations. AP 'I can't get any information from anybody. I've called the DeKalb County 911 number three times and left detailed information, and no one ever called us back. I don't know if he was involved. I need some help.' In another call, the dad specifically asked for one officer to call back given he'd helped with his son in the past. Advertisement 'He has been involved last summer with some problems we had with my adult son,' the elder White said of the cop. '[The officer] had left me his name and number and said if you guys need anything with Patrick, give me a call.' Records show there had been at least 10 emergency calls made from the White family home over the last two years, including for suicide threats and domestic disturbances. 3 Patrick Joseph Smith fired more than 180 shots into the CDC campus in Atlanta and broke 150 windows on Friday. AP It wasn't immediately clear if authorities returned the calls from White's dad during Friday's incident. Advertisement The shooter, who authorities said blamed the COVID-19 vaccine for making him depressed and suicidal, was found dead from a self-inflicted gunshot wound shortly after his rampage. Investigators said White had broken into a locked safe to get his father's weapons before he stormed the CDC's headquarters. CDC security guards had initially stopped White from driving into the campus Friday — so he parked near a pharmacy across the street and opened fire from the sidewalk, authorities said. 3 Police vehicles near Emory University and the CDC campus in Atlanta after the shooting on Aug. 8, 2025. Getty Images Advertisement His bullets broke about 150 'blast-resistant' windows across the campus. DeKalb County Police Officer David Rose was fatally shot while responding to the rampage, according to investigators. No one inside the CDC building was injured. In the aftermath, a search warrant at White's home uncovered a slew of written documents and electronic devices that are still being analyzed. Some of the materials 'expressed the shooter's discontent with the COVID-19 vaccinations' and his desire to make 'the public aware of his discontent with the vaccine,' Georgia Bureau of Investigation Director Chris Hosey said. With Post wires

DuPage County opening 24-hour crisis recovery center in Wheaton for mental health, substance use crises
DuPage County opening 24-hour crisis recovery center in Wheaton for mental health, substance use crises

CBS News

timean hour ago

  • CBS News

DuPage County opening 24-hour crisis recovery center in Wheaton for mental health, substance use crises

The DuPage County Crisis Recovery Center is a first-of-its-kind facility offering help for people experiencing mental health or substance abuse crises in the suburbs. The center provides services for both youth and adults. County officials say the center should reduce unnecessary visits to hospital emergency departments, and reduce interactions with law enforcement that both strain public resources and are often not suited to address behavioral health crises. Instead of going to the hospital or police, family members, individuals and first responders will be able to bring patients directly to the crisis center for support and resources. The center is staffed by trained mental health and substance use professionals. Once immediate treatment is complete, the center will help patients connect to community resources for continued support. The center will be able to hold up to 42 people eat a time, and officials estimate it can help about 15,000 people each year. The staff of 160 includes psychiatrists, psychiatric nurses, case managers and people who have experienced mental health issues or substance use disorder. Their services will include a youth mental health unit for patients aged 5 to 17 with family-centered services, an adult mental health unit and an adult substance use stabilization unit with 24-hour sobering care and support and medical withdrawal management. The center will open its physical doors in Wheaton to patients the week of Sept. 2. To get immediate help before it's open call 630-627-1700. If you or someone you know is in need of support, call the national Suicide and Crisis Lifeline at 988 to speak with someone over the phone 24 hours a day, 7 days a week.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store